A group of bioengineers at UC Berkeley has been hard at work hatching a new "heart-on-a-chip" technology that aims to offer researchers a better, less expensive way to develop new drugs.
Swiss med tech Xeltis has raised €27 million ($34 million) in an oversubscribed Series B round. The financing will be used mostly to help get its first product to market, a biodegradable pulmonary valve intended for patients with severe congenital malformations of the heart, an orphan pediatric indication.
Researchers in Italy have found microRNAs (miRNAs), tiny fragments of genetic material, that regenerate tissue in mouse hearts.
Doctors use a 50-year-old invasive heart imaging test known as a left ventriculography or left ventriculogram much too often, a Stanford University School of Medicine study concludes.
A scientist with the Gladstone Institutes, a nonprofit biomedical research foundation affiliated with University of California, San Francisco, has discovered how a gene regulator controls a mechanism
Time again to consider the carbon nanotube, that seemingly magical material that has been put forth as an answer to everything from semiconductor interconnects to drug delivery devices to
Heart failure, the most-common cause of hospitalization in North American adults, might be turned on by simply flicking a switch--a "pink" one. It's actually a protein switch called PINK1, and it can
Nicholas Wade of The New York Times has a little fun with the names scientists give genes when they're discovered in lab animals. Hippo, Warts, Merlin, Yorkie, Scalloped, Shaggy, Frizzled,
Songwriters may think that only love can mend a heart, but University of Miami cardiologists found that stem cell therapy can do it, too. In a small, preliminary human study, the researchers used
Potential heart treatments could be tested on human cells in a lab dish, rather than in mice, thanks to new stem cell technology. Stanford University researchers used skin cells from children with